[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Charles River Laboratories Earnings Preview: What to Expect

With a market cap of $10.8 billion, Charles River Laboratories International, Inc. (CRL) is a global partner to pharmaceutical and biotechnology companies, government agencies, and leading academic institutions, providing essential products and services that accelerate research and drug development. With a dedicated team focused on innovation and quality, the company helps clients expedite the discovery, early-stage development, and safe manufacture of new therapies for patients worldwide.

The Wilmington, Massachusetts-based company is slated to announce its fiscal Q2 2026 results before the market opens on Wednesday, Aug. 5. Ahead of the event, analysts expect CRL to report an adjusted EPS of $2.72,...

Fundamentals

See More
  • Market Capitalization, $K 175,365,744
  • Shares Outstanding, K 1,741,813
  • Annual Sales, $ 44,328 M
  • Annual Income, $ 6,524 M
  • EBIT $ 9,389 M
  • EBITDA $ 12,505 M
  • 60-Month Beta 0.61
  • Price/Sales 3.88
  • Price/Cash Flow 14.14
  • Price/Book 3.27

Options Overview Details

View History
  • Implied Volatility 29.55% (+0.05%)
  • Historical Volatility 39.09%
  • IV Percentile 73%
  • IV Rank 61.38%
  • IV High 37.47% on 07/15/26
  • IV Low 16.97% on 08/12/25
  • Expected Move (DTE 4) 2.45 (2.40%)
  • Put/Call Vol Ratio 0.26
  • Today's Volume 18,362
  • Volume Avg (30-Day) 14,383
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 224,246
  • Open Int (30-Day) 229,890
  • Expected Range 99.34 to 104.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 29 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $1.41
  • Number of Estimates 8
  • High Estimate $1.42
  • Low Estimate $1.40
  • Prior Year $1.30
  • Growth Rate Est. (year over year) +8.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
87.21 +16.78%
on 06/22/26
102.46 -0.61%
on 07/20/26
+13.43 (+15.19%)
since 06/18/26
3-Month
81.97 +24.24%
on 05/11/26
102.46 -0.61%
on 07/20/26
+5.84 (+6.08%)
since 04/20/26
52-Week
81.97 +24.24%
on 05/11/26
137.49 -25.93%
on 09/22/25
-21.83 (-17.65%)
since 07/18/25

Most Recent Stories

More News
Charles River Laboratories Earnings Preview: What to Expect

Charles River Laboratories is poised to announce its second-quarter results next month, and analysts predict a double-digit drop in the company’s bottom-line figure.

ABT : 101.43 (+0.74%)
XLV : 159.57 (-0.94%)
$SPX : 7,454.44 (-0.04%)
CRL : 220.66 (-1.64%)
What to Expect From Bio-Techne's Next Quarterly Earnings Report

Bio-Techne is scheduled to post its fourth-quarter results soon, and analysts project a single-digit earnings decline.

TECH : 71.64 (-0.67%)
ABT : 101.43 (+0.74%)
XLV : 159.57 (-0.94%)
$SPX : 7,454.44 (-0.04%)
Cencora Earnings Preview: What to Expect

Cencora is scheduled to release its third-quarter results next month, with analysts projecting single-digit earnings growth.

ABT : 101.43 (+0.74%)
XLV : 159.57 (-0.94%)
$SPX : 7,454.44 (-0.04%)
COR : 304.50 (-1.10%)
Nasdaq Futures Plunge as Chip Selloff Deepens; Netflix Sinks on Disappointing Forecast

September Nasdaq 100 E-Mini futures (NQU26) are down -1.61% this morning as the global selloff in chip stocks deepened.

NFLX : 67.65 (-1.89%)
NVDA : 202.99 (+0.09%)
META : 650.11 (+0.63%)
SNDK : 1,390.00 (+2.60%)
HL : 14.37 (+0.28%)
CDE : 14.20 (-1.05%)
NQU26 : 28,848.50 (+0.26%)
ASTS : 57.40 (-0.69%)
TFC : 50.97 (-2.91%)
FITB : 57.61 (-0.69%)
ABT : 101.43 (+0.74%)
RF : 31.16 (-1.55%)
Stocks Settle Lower as Chipmakers and AI Stocks Slump

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.51%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.62%. September...

MSTR : 97.93 (+3.25%)
GOOGL : 353.23 (+1.86%)
SNDK : 1,390.00 (+2.60%)
HL : 14.37 (+0.28%)
CDE : 14.20 (-1.05%)
GLXY : 23.61 (+9.15%)
FDXF : 149.75 (-1.65%)
COIN : 160.35 (+2.06%)
CRWV : 73.62 (+0.56%)
STX : 802.51 (+1.89%)
WDC : 487.08 (+2.07%)
AMD : 507.34 (+2.34%)
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street

Abbott's Q2 results show solid organic growth, better-than-expected margins, and improved earnings guidance, easing concerns over the Exact Sciences acquisition and boosting ABT shares.

ABT : 101.43 (+0.74%)
Stocks Mixed as Weakness in Chipmakers Weighs

The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.96%. September E-mini S&P futures...

MSTR : 97.93 (+3.25%)
SNDK : 1,390.00 (+2.60%)
HL : 14.37 (+0.28%)
CDE : 14.20 (-1.05%)
GLXY : 23.61 (+9.15%)
FDXF : 149.75 (-1.65%)
COIN : 160.35 (+2.06%)
STX : 802.51 (+1.89%)
WDC : 487.08 (+2.07%)
AMD : 507.34 (+2.34%)
UPS : 113.55 (-3.54%)
SCCO : 175.61 (+1.81%)
Stocks Pressured by a Renewed Selloff in Chipmakers

The S&P 500 Index ($SPX ) (SPY ) today is down -0.46%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.28%. September E-mini S&P futures...

MSTR : 97.93 (+3.25%)
SAIA : 427.51 (-2.14%)
UAL : 117.18 (+1.53%)
AVGO : 379.08 (+2.22%)
SNDK : 1,390.00 (+2.60%)
GLXY : 23.61 (+9.15%)
MRK : 124.52 (-2.34%)
TXN : 285.08 (+0.37%)
FDXF : 149.75 (-1.65%)
$IUXX : 28,688.04 (+0.33%)
COIN : 160.35 (+2.06%)
ARCB : 158.36 (-0.91%)
Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales

Abbott Laboratories (NYSE:ABT) Surprises With Q2 CY2026 Sales

ABT : 101.43 (+0.74%)
Zoetis Earnings Preview: What to Expect

Zoetis is set to post its second-quarter results next month, and analysts project a single-digit earnings rise.

ABT : 101.43 (+0.74%)
XLV : 159.57 (-0.94%)
$SPX : 7,454.44 (-0.04%)
ZTS : 76.00 (-0.04%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 104.71
2nd Resistance Point 103.42
1st Resistance Point 102.05
Last Price 101.43
1st Support Level 99.39
2nd Support Level 98.10
3rd Support Level 96.73

See More

52-Week High 137.49
Fibonacci 61.8% 116.28
Fibonacci 50% 109.73
Fibonacci 38.2% 103.18
Last Price 101.43
52-Week Low 81.97

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.